AI startups and high-growth companies require more than just funding to be successful. We understand that.
In today's hyper-competitive, global marketplace, having relevant and advantage-producing IP assets is critical. We provide funding, IP assets (e.g., licenses to patents and technologies), and tools to help companies successfully scale both nationally and internationally.
VC In The Era Of AI:
Where Capital Meets IP Assets.
Startup and growth funding is available through traditional VC and PE. But, VC and PE firms typically do not provide IP assets that enable their portfolio companies to attract customers, defend their product and market, and quickly scale both nationally and internationally.
We do!
We seek out teams that have a vision, deep domain knowledge and can execute. We provide the capital & assets.
01 / LICENSE TO HARDENED IP ASSETS
We provide licenses to a worldwide portfolio of hardened and stress-tested patents and technology that are relevant for the business and strategic advantage of the portfolio company.
02 / OFFENSIVE & DEFENSIVE TOOLS
We have significant experience with legal and other strategies and tools based on the IP assets that further protect our portfolio companies from new entrants and established competitors.
03 / NEW IP DEVELOPMENT
We work with our portfolio companies to develop new IP assets that further build upon our existing IP assets to enable additional competitive advantages and erect further barriers-to-entry.
04 / VENTURE FUNDING
We invest in high quality businesses and teams that have identified unique opportunities and are laser-focused on capitalizing on those market opportunities.
What Companies & CEOs Say
About The IP Assets
"...delivering the most advanced AI-powered mobile development and growth capabilities"
A startup founder from U.C. Berkeley had deep domain knowledge in computer science as well as in detecting disease, including cancers, through the analysis of various medical scans, including Optical Coherence Tomography (OCT) scans, Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans and Positron Emission Tomography (PET) scans.
Using the IP assets and other tools, he was able to turn his vision for an AI-based system for detecting cancers and other diseases into a fully operational system within two-weeks. He was then able to move to validation studies, and start to approach customers and partners.
When another company entered the market with a similar solution, the startup was able to work with The Lit Ventures to address the issue.
If you have a vision, deep domain knowledge and can execute, come work with us.
IP ASSETS.
Please do NOT send any confidential and/or proprietary materials. Any materials sent to us will be understood to be non-confidential and non-proprietary.